The outcome measures of pneumatic compression versus high-frequency vibration on quality of life in diabetic polyneuropathy patients - Trial PACTR202309863893315
Access comprehensive clinical trial information for PACTR202309863893315 through Pure Global AI's free database. This Phase 1 trial is sponsored by kafr el sheikh general hospital and is currently Completed. The study focuses on Nervous System Diseases; Nutritional, Metabolic, Endocrine.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Pan Africa Clinical Trials Registry data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
kafr el sheikh general hospital
mohamed shawky el iraqi
Timeline & Enrollment
Phase 1
Jul 01, 2023
Oct 01, 2023
Summary
neuropathy is nerve injury that starts with the longest nerves that innervate the toes and progresses proximally. Common symptoms are numbness, tingling, pain and/or weakness starting in the distal lower extremities. According to the International Diabetes Federation, 382 million people worldwide are currently affected by diabetes, one of the leading causes of neuropathy. The distal symmetrical polyneuropathy (DSPN) is the commonest clinical form of diabetic neuropathy, affecting more than 90% of the patients. Generally, DSPN affects the toes and distal foot, but slowly progresses proximally to involve the feet and legs in a stocking distribution.The purpose of the study is to compare the effect of pneumatic compression and high-intensity vibration on quality of life in diabetic polyneuropathy patients
ICD-10 Classifications
Data Source
Pan Africa Clinical Trials Registry
PACTR202309863893315
Device Trial